Search Results for:
-
ADVANCED BIOTHERAPY SEEKS FUNDING
After completing the initial clinical trial, ABCI plans to launch a secondary public stock offering to raise about $10 million for expanded clinical trials, Kelly saidBioWorld Today | Thursday, June 18, 1992 -
SOMATIX EXPANDS GENE THERAPY PATENT POSITION
Somatix said it aims to file with the FDA late this year an investigational new drug (IND) application on the procedure, which might put the method into a clinical trial in 1993BioWorld Today | Wednesday, June 17, 1992 -
BIOMIRA TO CONDUCT TESTS IN GERMANY
said Monday it has received regulatory approval for clinical trials of its Tru-Scint cancer in vivo diagnostic products in GermanyBioWorld Today | Tuesday, June 16, 1992 -
ORGANOGENESIS EYES MARKETING OPTIONS
Graftskin has been granted approval to enter multicenter clinical trials as a treatment for burns...of La Jolla, Calif., which has a dermal skin layer replacement product, Dermagraft, in clinical trialsBioWorld Today | Monday, June 15, 1992 -
APPOINTMENTS AND ADVANCEMENTS
The Menlo Park, Calif., company is conducting clinical trials on cell therapy devicesBioWorld Today | Monday, June 15, 1992 -
FDA APPROVES TESTING OF SECOND SPECIFID
Idec (NASDAQ:IDPH) is already conducting human clinical trials of an Idec-made Specifid antibodies in a treatment for non- Hodgkin's B-cell lymphomaBioWorld Today | Monday, June 15, 1992 -
EARLY DRUG DATA PLEASES IMMU
of San Diego, appear to be further along in clinical trials for therapeutics to treat B-cell lymphoma...ImmunoGen's immunoconjugate, Oncolysin B, entered clinical trials in 1988 and is about to start a Phase III multicenter trial that the company believes could provide the data needed for a product licensing application (PLA) in early 1994, Mark Ratner, ImmunoGen's director of external communications, said WednesdayBioWorld Today | Thursday, June 11, 1992 -
OCULON RAISES $9.4M IN FOURTH ROUND
According to Kinet, most of the $9.4 million will be used to fund clinical trials of pantethine, which is the company's patented compound for preventing cataracts...The most important thing at this point is to be able to get pantethine through clinical trials," Kinet saidBioWorld Today | Thursday, June 11, 1992 -
APACHE TO REVIEW LTIZ DATA
for review and analysis of safety and efficacy data from pivotal Phase III clinical trials of Amphocil...LTI (NASDAQ:LTIZ) said it also submitted a protocol for prospectively randomized, double-blind, parallel, multicenter clinical trials to compare daily doses of 4 mg/kg of Amphocil with daily doses of 1 mg/kg of amphtericin B in treating immunocompromised patients with documented invasive aspergillosis infection. (c) 1997 American Health ConsultantsBioWorld Today | Thursday, June 11, 1992 -
VCS OPTIMISTIC ABOUT START-UPS
We're looking for management credibility, proven track records in advancing research and clinical trials, and company milestones," such as patents and FDA approvalsBioWorld Today | Wednesday, June 10, 1992 -
ACNE TREATMENT TO LEAD GENTA'S IND PARADE
The acne drug, called G-101, has been shown to treat three major symptoms of acne in European clinical trials and would enter an existing market for topical acne treatments estimated at $758 million a yearBioWorld Today | Tuesday, June 9, 1992 -
HIRULOG ENTERS PHASE III TO TREAT ANGINA
announced Friday that it has begun Phase III clinical trials to study hirulog as a potential treatment for unstable anginaBioWorld Today | Monday, June 8, 1992 -
BRITISH BIO CROSSES THE POND FOR IPO
According to its IPO prospectus, BBG has two products in clinical trials, with another scheduled to enter trials this summer, all in the United KingdomBioWorld Today | Friday, June 5, 1992 -
XOMA'S E5 SUFFERS ANOTHER BLOW FROM FDA
Now it seems the FDA will require new clinical trials," he saidBioWorld Today | Friday, June 5, 1992 -
FDA PROTOCOL APPROVAL PROPELS CENTOCOR
The jump was triggered by an announcement on Wednesday morning of FDA approval of a protocol for a new Phase III clinical trial of the anti-bacterial drug CentoxinBioWorld Today | Thursday, June 4, 1992 -
NEORX CASHES IN ON STERLING DEAL
The company also has three cancer therapy product in clinical trials. -- Ray Potter Senior Editor (c) 1997 American Health ConsultantsBioWorld Today | Thursday, June 4, 1992 -
CEPHALON LICENSING PACT WITH KYOWA
Among the partners' short-term objectives is to narrow the field of potential molecules, which now comprises about 100 analogs, to a few lead compounds that would be moved toward clinical trialsBioWorld Today | Wednesday, June 3, 1992 -
IMMUCELL SUPPLY PACT WITH UNIVAX
ImmuCell's passive antibody technology for this application has received Orphan Drug designation and is now in Phase I clinical trials. (c) 1997 American Health ConsultantsBioWorld Today | Wednesday, June 3, 1992 -
CENTOCOR'S PLAN TO BOOST CENTOXIN IN EUROPE
marketing approval of Centoxin were dealt a setback by the FDA in April, should soon announce a protocol for another round of Phase III clinical trials to meet the agency's objections, said Michael Wall, who chairs the company's executive committeeBioWorld Today | Wednesday, June 3, 1992 -
EUROPEAN PATENT FOR CELL-SELECTION PROCESS
The FDA has approved Phase III clinical trials of its Ceprate SC Stem Cell concentration systems at five medical centers in conjunction with autologous bone marrow transplant to treat non-Hodgkin's lymphoma and recurring breast cancer, Parker saidBioWorld Today | Tuesday, June 2, 1992
Category
Current Filters
- xclinical trials
Related Keywords
Categories
- x BioWorld Today (9780)
- x BioWorld International (1967)
- x BioWorld Insight (1209)
- x Bio Perspectives (297)
- x State of the Industry Report (131)
- x BioWorld Genomics Review (58)
- x Top 25 Drug Report (43)
- x BioWorld Snapshots (29)
- x Biotech Innovations (17)
- x Market-Leading Biotech Drugs (12)
- x RNAi Report (11)
- x BioWorld Phase III Report (7)
- x Executive Compensation Report (4)
- x Recorded (4)
- x Upcoming (1)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.